Using Web-Based Questionnaires to Assess Medication Use During Pregnancy:A Validation Study in 2 Prospectively Enrolled Cohorts
Medication use is often underreported in paper-based questionnaires or interviews. Web-based questionnaires may improve recall of medication use, but data on their validity are currently lacking. Participants in the Pregnancy and Infant Development (PRIDE) Study (2014-2016; n = 557) and the Pregnancy Drug Registry (pREGnant) (2015-2016; n = 169) completed a 6-week paper-based medication diary during gestational weeks 19-24 or 26-31. In week 34, they completed a Web-based questionnaire with questions on medication names, time period and frequency of use, and quantity taken. To assess the degree... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2018 |
Reihe/Periodikum: | van Gelder , M M H J , Vorstenbosch , S , Te Winkel , B , van Puijenbroek , E P & Roeleveld , N 2018 , ' Using Web-Based Questionnaires to Assess Medication Use During Pregnancy : A Validation Study in 2 Prospectively Enrolled Cohorts ' , American Journal of Epidemiology , vol. 187 , no. 2 , pp. 326-336 . https://doi.org/10.1093/aje/kwx239 |
Schlagwörter: | Journal Article / MOTHERS / DESIGN / MATERNAL RECALL / DRUG-USE / BIRTH CHARACTERISTICS / DELIVERY / EXPOSURE / RECORDS / AGREEMENT / NETHERLANDS |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-27211623 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://hdl.handle.net/11370/eb166b71-4ef5-44f9-bd25-825089c068f0 |
Medication use is often underreported in paper-based questionnaires or interviews. Web-based questionnaires may improve recall of medication use, but data on their validity are currently lacking. Participants in the Pregnancy and Infant Development (PRIDE) Study (2014-2016; n = 557) and the Pregnancy Drug Registry (pREGnant) (2015-2016; n = 169) completed a 6-week paper-based medication diary during gestational weeks 19-24 or 26-31. In week 34, they completed a Web-based questionnaire with questions on medication names, time period and frequency of use, and quantity taken. To assess the degree of underreporting, we calculated the questionnaire's sensitivity using the medication diary as the reference standard. Sensitivity was high for many medication groups, including antiepileptic medication (sensitivity (Sn) = 0.96, 95% confidence interval (CI): 0.89, 1.00), antacids (Sn = 0.89, 95% CI: 0.86, 0.93), and iron preparations (Sn = 0.81, 95% CI: 0.64, 0.98). However, medications for short-term use were underreported more frequently, with sensitivities of 0.54 (95% CI: 0.35, 0.72) for antihistamines, 0.63 (95% CI: 0.57, 0.69) for analgesic and antipyretic agents, and 0.57 (95% CI: 0.51, 0.64) for acetaminophen. Shortening the period of time between exposure and questionnaire administration increased sensitivity substantially. In conclusion, underreporting in Web-based questionnaires is limited for many medication groups. In prospective studies, underreporting of medications for short-term use may be reduced by decreasing the interval between consecutive questionnaires.